Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A T Hart

Showing results (61-70 of 205) with videos related to

Pageof 21
Sort By:
Histopathology|July 19, 2018
Essential preanalytics in PD-L1 immunocytochemistryNils A T Hart, Jose van der Starre-Gaal, Judith M Vonk, et al.
Chemico-Biological Interactions|January 1, 1991
Metabolic activation of chlorpromazine by stimulated human polymorphonuclear leukocytes. Induction of covalent binding of chlorpromazine to nucleic acids and proteinsP P Kelder, N J de Mol, B A 'T Hart, et al.
Trends in Molecular Medicine|April 23, 2004
Non-invasive measurement of brain damage in a primate model of multiple sclerosisBert A 't Hart, Jack Vogels, Jan Bauer, et al.
Clinical and Experimental Immunology|May 1, 1994
Identification of antibody epitopes in the CB-11 peptide of bovine type II collagen recognized by sera from arthritis-susceptible and -resistant rhesus monkeysS Turner, N P Bakker, B A t Hart, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 8, 2021
Correction to: Quantitative comparison of PD-L1 IHC assays against NIST standard reference material 1934Seshi R Sompuram, Emina E Torlakovic, Nils A 't Hart, et al.
Chemico-Biological Interactions|January 1, 1990
How flavonoids inhibit the generation of luminol-dependent chemiluminescence by activated human neutrophilsB A 'T Hart, T R Ip Via Ching, H Van Dijk, et al.
Virchows Archiv : an International Journal of Pathology|September 16, 2025
HER2-low breast cancer in routine practice: a nationwide study of diagnostic variability across pathology laboratoriesZeynep E Kain, Ximena Baez-Navarro, Nils A 't Hart, et al.
Ebiomedicine|May 27, 2021
Multiple sclerosis and drug discovery: A work of translationBert A 't Hart, Antonio Luchicchi, Geert J Schenk, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 14, 2021
Quantitative comparison of PD-L1 IHC assays against NIST standard reference material 1934Seshi R Sompuram, Emina E Torlakovic, Nils A 't Hart, et al.
Drug Discovery Today|February 16, 2006
MRI-guided immunotherapy development for multiple sclerosis in a primateBert A 't Hart, Paul Smith, Sandra Amor, et al.
Pageof 21

Showing results (61-70 of 205) with videos related to

Sort By:
Pageof 21
Histopathology|July 19, 2018
Essential preanalytics in PD-L1 immunocytochemistryNils A T Hart, Jose van der Starre-Gaal, Judith M Vonk, et al.
Chemico-Biological Interactions|January 1, 1991
Metabolic activation of chlorpromazine by stimulated human polymorphonuclear leukocytes. Induction of covalent binding of chlorpromazine to nucleic acids and proteinsP P Kelder, N J de Mol, B A 'T Hart, et al.
Trends in Molecular Medicine|April 23, 2004
Non-invasive measurement of brain damage in a primate model of multiple sclerosisBert A 't Hart, Jack Vogels, Jan Bauer, et al.
Clinical and Experimental Immunology|May 1, 1994
Identification of antibody epitopes in the CB-11 peptide of bovine type II collagen recognized by sera from arthritis-susceptible and -resistant rhesus monkeysS Turner, N P Bakker, B A t Hart, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 8, 2021
Correction to: Quantitative comparison of PD-L1 IHC assays against NIST standard reference material 1934Seshi R Sompuram, Emina E Torlakovic, Nils A 't Hart, et al.
Chemico-Biological Interactions|January 1, 1990
How flavonoids inhibit the generation of luminol-dependent chemiluminescence by activated human neutrophilsB A 'T Hart, T R Ip Via Ching, H Van Dijk, et al.
Virchows Archiv : an International Journal of Pathology|September 16, 2025
HER2-low breast cancer in routine practice: a nationwide study of diagnostic variability across pathology laboratoriesZeynep E Kain, Ximena Baez-Navarro, Nils A 't Hart, et al.
Ebiomedicine|May 27, 2021
Multiple sclerosis and drug discovery: A work of translationBert A 't Hart, Antonio Luchicchi, Geert J Schenk, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 14, 2021
Quantitative comparison of PD-L1 IHC assays against NIST standard reference material 1934Seshi R Sompuram, Emina E Torlakovic, Nils A 't Hart, et al.
Drug Discovery Today|February 16, 2006
MRI-guided immunotherapy development for multiple sclerosis in a primateBert A 't Hart, Paul Smith, Sandra Amor, et al.
Pageof 21